Dendritic cells-based vaccine and immune monitoring for hepatocellular carcinoma

Korean Journal of Physiology and Pharmacology

Volumn 14, Issue 1, 2010, Pages 11-14

  Lee, Dae Heui ^a  

^a Kosin University   (South Korea)

Author keywords

Cancer immunotherapy; Dendritic cells (DCs); Hepatocellular carcinoma; Natural killer (NK) cells; Peripheral blood stem cells (PBSCs)

Indexed keywords

DENDRITIC CELL VACCINE; FLT3 LIGAND; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CANCER IMMUNIZATION; CELL ACTIVITY; CELL FUNCTION; CELL STRUCTURE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; LIVER CELL CARCINOMA; NATURAL KILLER CELL; PERIPHERAL BLOOD STEM CELL;

EID: 77949850522     PISSN: 12264512     EISSN: None     Source Type: Journal    
DOI: 10.4196/kjpp.2010.14.1.11     Document Type: Article

References (17)

1. Steinman RM. The dendritic cell system and its role in immunogenicity. Ann Rev Immunol. 1991;9:271-296.
2. Lee DH, Park JS, Eo WK, Kim WM, Kang K. Differentiation induction of dendritic cell phenotypes from human leukemic cell lines. Korean J Physiol Pharmacol. 2001;5:79-86.
3. + hematopoietic progenitor cells. Blood. 1995;86:3413-3420.
4. Young CJ, Varma A, DiGiusto D, Backer MP. Retention of quiescent hematopoietic cells with high proliferative potential during ex vivo stem cell culture. Blood. 1996;87:545-556.
5. Piacibello W, Sanavio F, Garetto L, Severino A, Bergandi D, Ferrario J, Fagioli F, Berger M, Aglietta M. Extensive amplification and self-renewal of human primitive hematopoietic stem cells from cord blood. Blood. 1997;89:2644-2653.
6. Lyman SD, James L, Johnson L, Brasel K, de Vries P, Escobar SS, Downey H, Splett RR, Beckman MP, McKenna HJ. Cloning of the human homologue of the murine flt3 ligand: a growth factor for early hematopoietic progenitor cells. Blood. 1994;83: 2795-2801.
7. Pardoll DM. Cancer vaccines. Nat Med. 1998;4:525-531.
8. Ockert D, Schmitz M, Hampl M, Rieber EP. Advances in cancer immunotherapy. Immunol Today. 1999;20:63-65.
9. Nestle FO, Burg G, Dummer R. New perspectives on immunobiology and immunotherapy of melanoma. Immunol Today. 1999;20:5-7.
10. Boon T, Coulie PG, Van den Eynde B. Tumor antigens recognized by T cells. Immunol Today. 1997;18:267-268.
11. Steinman RM. Dendritic cells and immune-based therapies. Exp Hematol. 1996;24:859-862.
12. Schuler G, Steinman RM Dendritic cells as adjuvants for immune-mediated resistance to tumors. J Exp Med. 1997;186:1183-1187.
13. Lotze MT. Getting to the source: dendritic cells as therapeutic reagents for the treatment of patients with cancer. Ann Surg. 1997;226:1-5.
14. Colaco C. DC-based cancer immunotherapy: the sequel. Immunol Today. 1999;20:197-198.
15. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature. 1998;392:245-252.
16. Bottomly K. Immunology-T cells and dendritic cells get intimate. Science. 1999;283:1124-1125.
17. Fernandez NC, Lozier A, Flament C. Dendritic cells directly trigger NK cell functions: Cross-talk relevant in innate anti-tumor immune responses in vivo. Nat Med. 1999;5:405-411.